SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-274515
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:59
Documents
13
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d295356d8k.htm   iXBRL 8-K 24420
2 EX-99.1 d295356dex991.htm EX-99.1 96260
  Complete submission text file 0001193125-23-274515.txt   256914

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ino-20231109.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20231109_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20231109_pre.xml EX-101.PRE 11259
7 EXTRACTED XBRL INSTANCE DOCUMENT d295356d8k_htm.xml XML 3356
Mailing Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121
Business Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

IRS No.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 231392675
SIC: 3841 Surgical & Medical Instruments & Apparatus